An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Quality Assistance Ltd. is seeking several scientists to contribute to analytical data supporting the development of innovative therapies. You will join a Bioassays team, performing routine assays through to method development, optimization and validation for diverse client projects.
Reporting to the Technical Leader Bioassays, you will work with 5–6 scientists to ensure quality, reliability and regulatory compliance of medicines in development.
Ready to contribute to the quality and safety of life-changing therapies? Here's what awaits you.
As part of the growth of our Bioassays activities and the expansion of our laboratories, we are looking for several scientists to contribute to the analytical data that supports the development of innovative therapies. Depending on your expertise, you will be involved in a broad range of activities, from routine assay execution to method development, optimisation and validation for diverse client projects.
Reporting to the Technical Leader Bioassays, you will join a team of 5 to 6 scientists, in which every experiment, analysis and insight contributes to the quality, reliability and regulatory compliance of medicines in development.
To succeed in this role, you'll bring:
At Quality Assistance, your scientific development is just as important as the projects you contribute to. We provide an environment where curiosity, learning and collaboration are encouraged every day. You can expect:
Quality Assistance is a leading European analytical CRO dedicated to accelerating the development of innovative medicines. For more than 40 years, we have supported pharmaceutical and biotechnology companies by delivering analytical expertise that meets EMA and FDA regulatory standards.
From a single integrated site in Belgium, our 280+ professionals work with advanced technologies to support complex modalities including biologics, oligonucleotides, peptides, mRNA, cell and gene therapies, vaccines and nanomedicines. Having contributed to more than 2,000 drug candidates, we continue to expand our capabilities while remaining committed to scientific excellence, operational rigour and trusted partnerships.